Anti-SARS-CoV-2 and cytotoxic activity of two marine alkaloids from green alga Caulerpa cylindracea Sonder in the Dardanelles. Issue 46 (19th October 2022)
- Record Type:
- Journal Article
- Title:
- Anti-SARS-CoV-2 and cytotoxic activity of two marine alkaloids from green alga Caulerpa cylindracea Sonder in the Dardanelles. Issue 46 (19th October 2022)
- Main Title:
- Anti-SARS-CoV-2 and cytotoxic activity of two marine alkaloids from green alga Caulerpa cylindracea Sonder in the Dardanelles
- Authors:
- Erol, Ebru
Orhan, Muge Didem
Avsar, Timucin
Akdemir, Atilla
Okudan, Emine Sukran
Alim Toraman, Gulbahar Ozge
Topcu, Gulacti - Abstract:
- Abstract : Isolated compounds 1 and 2 from Caulerpa cyclindracea inhibit the SARS-CoV-2 spike protein. Modelling studies suggest that the compounds may interfere with the spike-ACE2 interaction directly and also via an interaction with a spike allosteric site. Abstract : Caulerpa cylindracea Sonder is a green alga belonging to the Caulerpaceae family. This is the first chemical investigation of C. cylindracea in the Dardanelles which resulted in the isolation of four compounds, caulerpin (1 ), monomethyl caulerpinate (2 ), beta-sitosterol (3 ), and palmitic acid (4 ). Their structures were elucidated by spectroscopic analyses including 1D- and 2D NMR and mass. The isolated compounds 1 and 2 were tested against the SARS-CoV-2 viral targets spike protein and main protease (3CL) enzyme, and both compounds significantly inhibit the interaction of spike protein and ACE2, while the main protease activity was not significantly reduced. Docking studies suggested that compounds 1 and 2 may bind to the ACE2 binding pocket on spike, and compound 2 may also bind to an allosteric site on spike. As such, these compounds may inhibit the spike–ACE2 complex formation competitively and/or allosterically and have the potential to be used against SARS-CoV-2 virus infection. In addition, compounds 1 and 2 showed at least two-fold higher cytotoxicity against breast cancer cell lines MCF7 and MDA-MB-231 compared to the CCD fibroblast control cell line.
- Is Part Of:
- RSC advances. Volume 12:Issue 46(2022)
- Journal:
- RSC advances
- Issue:
- Volume 12:Issue 46(2022)
- Issue Display:
- Volume 12, Issue 46 (2022)
- Year:
- 2022
- Volume:
- 12
- Issue:
- 46
- Issue Sort Value:
- 2022-0012-0046-0000
- Page Start:
- 29983
- Page End:
- 29990
- Publication Date:
- 2022-10-19
- Subjects:
- Chemistry -- Periodicals
540.5 - Journal URLs:
- http://pubs.rsc.org/en/Journals/JournalIssues/RA ↗
http://www.rsc.org/ ↗ - DOI:
- 10.1039/d2ra03358e ↗
- Languages:
- English
- ISSNs:
- 2046-2069
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 8036.750300
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 24206.xml